Home Latest Strides Pharma to conduct trials of Favipiravir, considered as potential treatment for COVID-19

Strides Pharma to conduct trials of Favipiravir, considered as potential treatment for COVID-19

by the owl speaks

At one time, scientists around the world are trying to find a coronavirus vaccine, Pharmaceutical company Strides Pharma Science said on Thursday it obtained regulatory approval to perform clinical trials of antiviral drug favipiravir, considered a possible COVID-19 therapy. The Bengaluru-based firm has been approved by India ‘s Drug Controller General for conducting favipiravir trials in the region.

You may also like

Leave a Comment

so